JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Žák, John R. Teijaro, Livia Hegerova et al.|Science|2024Cited by 173
Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signalingBrett S. Marro, Michael B. A. Oldstone, Brian C. Ware et al.|Proceedings of the National Academy of Sciences|2017Cited by 69
Discovery of Small Molecules for the Reversal of T Cell ExhaustionBrett S. Marro, Michael B. A. Oldstone, Jaroslav Žák et al.|Cell Reports|2019Cited by 49
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapyJaroslav Žák, John R. Teijaro, Judith A. Varner et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 6